| 1 |
Baek EB, Yoo HY, Park SJ, Chung YS, Hong EK, Kim SJ. Inhibition of arterial myogenic responses by a mixed aqueous extract of salvia miltiorrhiza and Panax notoginseng (PASEL) showing antihypertensive effects. Korean J Physiol Pharmacol 2009;13:287-293.
과학기술학회마을
DOI
ScienceOn
|
| 2 |
Wagner HN, Liu X. The international textbook of cardiology. New York: Pergamon Press, 1987.
|
| 3 |
Liu L, Shi R, Shi Q, Cheng Y, Huo Y. Protective effect of saponins from Panax notoginseng against doxorubicininduced cardiotoxicity in mice. Planta Med 2008;74:203-209.
DOI
ScienceOn
|
| 4 |
Qin N, Gong QH, Wei LW, Wu Q, Huang XN. Total ginsenosides inhibit the right ventricular hypertrophy induced by monocrotaline in rats. Biol Pharm Bull 2008;31:1530-1535.
DOI
ScienceOn
|
| 5 |
Deng J, Wang YW, Chen WM, Wu Q, Huang XN. Role of nitric oxide in ginsenoside Rg(1)-induced protection against left ventricular hypertrophy produced by abdominal aorta coarctation in rats. Biol Pharm Bull 2010; 33:631-635.
DOI
ScienceOn
|
| 6 |
Wang YG, Zima AV, Ji X, Pabbidi R, Blatter LA, Lipsius SL. Ginsenoside Re suppresses electromechanical alternans in cat and human cardiomyocytes. Am J Physiol Heart Circ Physiol 2008;295:H851-H859.
DOI
ScienceOn
|
| 7 |
Wang Z, Li M, Wu WK, Tan HM, Geng DF. Ginsenoside  preconditioning protects against myocardial infarction after regional ischemia and reperfusion by activation of phosphatidylinositol-3-kinase signal transduction. Cardiovasc Drugs Ther 2008;22:443-452.
DOI
ScienceOn
|
| 8 |
Deng J, Lv XT, Wu Q, Huang XN. Ginsenoside Rg(1) inhibits rat left ventricular hypertrophy induced by abdominal aorta coarctation: involvement of calcineurin and mitogen-activated protein kinase signalings. Eur J Pharmacol 2009;608:42-47.
DOI
ScienceOn
|
| 9 |
Wang YL, Wang CY, Zhang BJ, Zhang ZZ. Shenfu injection suppresses apoptosis by regulation of Bcl-2 and caspase-3 during hypoxia/reoxygenation in neonatal rat cardiomyocytes in vitro. Mol Biol Rep 2009;36:365-370.
DOI
|
| 10 |
Zhou DH. Preventive geriatrics: an overview from traditional Chinese medicine. Am J Chin Med 1982;10:32-39.
DOI
ScienceOn
|
| 11 |
Brekhman II. Panax ginseng. Leningrad: Gosudaarst Isdat et Med Lit, 1957.
|
| 12 |
Jiang QS, Huang XN, Dai ZK, Yang GZ, Zhou QX, Shi JS, Wu Q. Inhibitory effect of ginsenoside Rb1 on cardiac hypertrophy induced by monocrotaline in rat. J Ethnopharmacol 2007;111:567-572.
DOI
ScienceOn
|
| 13 |
Cai BX, Li XY, Chen JH, Tang YB, Wang GL, Zhou JG, Qui QY, Guan YY. Ginsenoside-Rd, a new voltage-independent Ca2+ entry blocker, reverses basilar hypertrophic remodeling in stroke-prone renovascular hypertensive rats. Eur J Pharmacol 2009;606:142-149.
DOI
ScienceOn
|
| 14 |
Chen RJ, Chung TY, Li FY, Lin NH, Tzen JT. Effect of sugar positions in ginsenosides and their inhibitory potency on Na+/K+-ATPase activity. Acta Pharmacol Sin 2009;30:61-69.
DOI
ScienceOn
|
| 15 |
Choi SH, Lee JH, Pyo MK, Lee BH, Shin TJ, Hwang SH, Kim BR, Lee SM, Oh JW, Kim HC et al. Mutations Leu427, Asn428, and Leu431 residues within transmembrane domain-I-segment 6 attenuate ginsenoside-mediated L-type Ca(2+) channel current inhibitions. Biol Pharm Bull 2009;32:1224-1230.
DOI
ScienceOn
|
| 16 |
Jeon BH, Kim CS, Park KS, Lee JW, Park JB, Kim KJ, Kim SH, Chang SJ, Nam KY. Effect of Korea red ginseng on the blood pressure in conscious hypertensive rats. Gen Pharmacol 2000;35:135-141.
DOI
ScienceOn
|
| 17 |
Kang SY, Schini-Kerth VB, Kim ND. Ginsenosides of the protopanaxatriol group cause endothelium-dependent relaxation in the rat aorta. Life Sci 1995;56:1577-1586.
DOI
ScienceOn
|
| 18 |
Shibata S, Fujita M, Itokawa H, Tanaka O, Ishii T. Studies on the constituents of Japanese and Chinese crude drugs. XI. Panaxadiol, a sapogenin of ginseng roots. Chem Pharm Bull (Tokyo) 1963;11:759-761.
DOI
ScienceOn
|
| 19 |
Vuksan V, Stavro M, Woo M, Leiter LA, Sung MK, Sievenpiper JL. Korean red ginseng (Panax ginseng) can lower blood pressure in individuals with hypertension: a randomized controlled trial. Proceedings of the 9th International Ginseng Symposium; 2006 Sep 25-28; Geumsan, Korea. Seoul: Korean Society of Ginseng, 2006.
|
| 20 |
Kim ND, Kang SY, Schini VB. Ginsenosides evoke endothelium- dependent vascular relaxation in rat aorta. Gen Pharmacol 1994;25:1071-1077.
DOI
ScienceOn
|
| 21 |
Shibata S, Tanaka O, Soma K, Ando T, Iida Y, Nakamura H. Studies on saponins and sapogenins of ginseng. The structure of panaxatriol. Tetrahedron Lett 1965;42:207-213.
|
| 22 |
Gillis CN. Panax ginseng pharmacology: a nitric oxide link? Biochem Pharmacol 1997;54:1-8.
DOI
ScienceOn
|
| 23 |
Buettner C, Yeh GY, Phillips RS, Mittleman MA, Kaptchuk TJ. Systematic review of the effects of ginseng on cardiovascular risk factors. Ann Pharmacother 2006;40:83-95.
|
| 24 |
Hofseth LJ, Wargovich MJ. Inflammation, cancer, and targets of ginseng. J Nutr 2007;137(1 Suppl):183S-185S.
|
| 25 |
Attele AS, Wu JA, Yuan CS. Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol 1999;58:1685-1693.
DOI
ScienceOn
|
| 26 |
Zhou W, Chai H, Lin PH, Lumsden AB, Yao Q, Chen CJ. Molecular mechanisms and clinical applications of ginseng root for cardiovascular disease. Med Sci Monit 2004;10:RA187- RA192.
|
| 27 |
Cheng Y, Shen LH, Zhang JT. Anti-amnestic and anti-aging effects of ginsenoside  and and its mechanism of action. Acta Pharmacol Sin 2005;26:143-149.
DOI
ScienceOn
|
| 28 |
Brekhman II, Dardymov IV. New substances of plant origin which increase nonspecific resistance. Annu Rev Pharmacol 1969;9:419-30.
DOI
ScienceOn
|
| 29 |
Fuzzati N. Analysis methods of ginsenosides. J Chromatogr B Analyt Technol Biomed Life Sci 2004;812:119-133.
|
| 30 |
Nah SY, Kim DH, Rhim H. Ginsenosides: are any of them candidates for drugs acting on the central nervous system? CNS Drug Rev 2007;13:381-404.
|
| 31 |
Bittles AH, Fulder SJ, Grant EC, Nicholls MR. The effect of ginseng on lifespan and stress responses in mice. Gerontology 1979;25:125-131.
DOI
ScienceOn
|
| 32 |
Ulrich S, Hingorani AD, Martin J, Vallance P. Lifetime risk of developing coronary heart disease. Lancet 1999;353:925.
|
| 33 |
Tunstall-Pedoe H, Vanuzzo D, Hobbs M, Mahonen M, Cepaitis Z, Kuulasmaa K, Keil U. Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations. Lancet 2000;355:688-700.
DOI
ScienceOn
|
| 34 |
Toth PP. Making a case for quantitative assessment of cardiovascular risk. J Clin Lipidol 2007;1:234-241.
DOI
ScienceOn
|
| 35 |
Libby P. What have we learned about the biology of atherosclerosis? The role of infl ammation. Am J Cardiol 2001;88(7B):3J-6J.
|
| 36 |
Libby P. Act local, act global: infl ammation and the multiplicity of "vulnerable" coronary plaques. J Am Coll Cardiol 2005;45:1600-1602.
DOI
ScienceOn
|
| 37 |
Davies MJ, Gordon JL, Gearing AJ, Pigott R, Woolf N, Katz D, Kyriakopoulos A. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J Pathol 1993;171:223-229.
DOI
ScienceOn
|
| 38 |
Schechter CB. Longevity and cardiovascular disease: context and overview. Arch Intern Med 2007;167:428-429.
DOI
ScienceOn
|
| 39 |
Tabas I. Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency. Arterioscler Thromb Vasc Biol 2005;25:2255-2264.
DOI
ScienceOn
|
| 40 |
Tabas I, Williams KJ, Boren J. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation 2007;116:1832-1844.
DOI
ScienceOn
|
| 41 |
Boudina S, Laclau MN, Tariosse L, Daret D, Gouverneur G, Bonoron-Adele S, Saks VA, Dos Santos P. Alteration of mitochondrial function in a model of chronic ischemia in vivo in rat heart. Am J Physiol Heart Circ Physiol 2002;282:H821-H831.
|
| 42 |
Chen X. Cardiovascular protection by ginsenosides and their nitric oxide releasing action. Clin Exp Pharmacol Physiol 1996;23:728-732.
DOI
ScienceOn
|
| 43 |
Kritharides L, Brown A, Brieger D, Ridell T, Zeitz C, Jeremy R, Tonkin A, Walsh W, White H. Overview and determinants of cardiovascular disease in indigenous populations. Heart Lung Circ 2010;19:337-343.
DOI
ScienceOn
|
| 44 |
Pratt C. Alternative prevention and treatment of cardiovascular disease, part 2. Prim Care 2010;37:339-366.
DOI
ScienceOn
|
| 45 |
Li XT, Chen R, Jin LM, Chen HY. Regulation on energy metabolism and protection on mitochondria of Panax ginseng polysaccharide. Am J Chin Med 2009;37:1139-1152.
DOI
ScienceOn
|
| 46 |
Li J, Ichikawa T, Jin Y, Hofseth LJ, Nagarkatti P, Nagarkatti M, Windust A, Cui T. An essential role of Nrf2 in American ginseng-mediated anti-oxidative actions in cardiomyocytes. J Ethnopharmacol 2010;130:222-230.
DOI
ScienceOn
|
| 47 |
Fu Y, Ji LL. Chronic ginseng consumption attenuates age-associated oxidative stress in rats. J Nutr 2003;133:3603-3609.
|
| 48 |
Zhou W, Chai H, Lin PH, Lumsden AB, Yao Q, Chen C. Ginsenoside blocks homocysteine-induced endothelial dysfunction in porcine coronary arteries. J Vasc Surg 2005;41:861-868.
DOI
ScienceOn
|
| 49 |
Wang X, Chai H, Yao Q, Chen C. Molecular mechanisms of HIV protease inhibitor-induced endothelial dysfunction. J Acquir Immune Defi c Syndr 2007;44:493-499.
DOI
ScienceOn
|
| 50 |
Xie JT, Shao ZH, Vanden Hoek TL, Chang WT, Li J, Mehendale S, Wang CZ, Hsu CW, Becker LB, Yin JJ et al. Antioxidant effects of ginsenoside Re in cardiomyocytes. Eur J Pharmacol 2006;532:201-207.
DOI
ScienceOn
|
| 51 |
Deng HL, Zhang JT. Anti-lipid peroxilative effect of ginsenoside and . Chin Med J (Engl) 1991;104:395-398.
|
| 52 |
Lim JH, Wen TC, Matsuda S, Tanaka J, Maeda N, Peng H, Aburaya J, Ishihara K, Sakanaka M. Protection of ischemic hippocampal neurons by ginsenoside , a main ingredient of ginseng root. Neurosci Res 1997;28:191-200.
DOI
ScienceOn
|
| 53 |
Xie YW, Shen W, Zhao G, Xu X, Wolin MS, Hintze TH. Role of endothelium-derived nitric oxide in the modulation of canine myocardial mitochondrial respiration in vitro. Implications for the development of heart failure. Circ Res 1996;79:381-387.
DOI
ScienceOn
|
| 54 |
Tian J, Fu F, Geng M, Jiang Y, Yang J, Jiang W, Wang C, Liu K. Neuroprotective effect of 20(S)-ginsenoside  on cerebral ischemia in rats. Neurosci Lett 2005;374:92-97.
DOI
ScienceOn
|
| 55 |
Lu JM, Yao Q, Chen C. Ginseng compounds: an update on their molecular mechanisms and medical applications. Curr Vasc Pharmacol 2009;7:293-302.
DOI
ScienceOn
|
| 56 |
Zweier JL, Flaherty JT, Weisfeldt ML. Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proc Natl Acad Sci U S A 1987;84:1404-1407.
DOI
ScienceOn
|
| 57 |
Taniguchi M, Wilson C, Hunter CA, Pehowich DJ, Clanachan AS, Lopaschuk GD. Dichloroacetate improves cardiac effi ciency after ischemia independent of changes in mitochondrial proton leak. Am J Physiol Heart Circ Physiol 2001;280:H1762- H1769.
|
| 58 |
Abdel-Wahhab MA, Ahmed HH. Protective effect of Korean Panax ginseng against chromium VI toxicity and free radicals generation in rats. J Ginseng Res 2004;28:11-17.
과학기술학회마을
|
| 59 |
Chung YH, Kim KW, Oura H. Effects of ginsenoside  on the anti-oxidants in senescence-accelerated mice (SAM-R/1). Proceedings of the 6th Internationa1 Ginseng Symposium; 1993 Sep 6-9; Seoul, Korea. Daejeon: Korea Ginseng & Tobacco Research Institute, 1993.
|
| 60 |
Chang HM; Chinese University of Hong Kong; Chinese Medicinal Research Centre. Advances in Chinese medicinal materials research. Philadelphia: World Scientifi c, 1985.
|
| 61 |
Kim H, Chen X, Gillis CN. Ginsenosides protect pulmonary vascular endothelium against free radical-induced injury. Biochem Biophys Res Commun 1992;189:670-676.
DOI
ScienceOn
|
| 62 |
Zhang YG, Zhang HG, Zhang GY, Fan JS, Li XH, Liu YH, Li SH, Lian XM, Tang Z. Panax notoginseng saponins attenuate atherosclerosis in rats by regulating the blood lipid profi le and an anti-infl ammatory action. Clin Exp Pharmacol Physiol 2008;35:1238-1244.
DOI
ScienceOn
|
| 63 |
Kim YK, Guo Q, Packer L. Free radical scavenging activity of red ginseng aqueous extracts. Toxicology 2002;172:149-156.
DOI
ScienceOn
|
| 64 |
Samukawa K, Suzuki Y, Ohkubo N, Aoto M, Sakanaka M, Mitsuda N. Protective effect of ginsenosides Rg(2) and Rh(1) on oxidation-induced impairment of erythrocyte membrane properties. Biorheology 2008;45:689-700.
|
| 65 |
Hwang SY, Son DJ, Kim IW, Kim DM, Sohn SH, Lee JJ, Kim SK. Korean red ginseng attenuates hypercholesterolemia- enhanced platelet aggregation through suppression of diacylglycerol liberation in high-cholesterol-diet-fed rabbits. Phytother Res 2008;22:778-783.
DOI
ScienceOn
|
| 66 |
Liu G, Wang B, Zhang J, Jiang H, Liu F. Total panax notoginsenosides prevent atherosclerosis in apolipoprotein E-knockout mice: role of downregulation of CD40 and MMP-9 expression. J Ethnopharmacol 2009;126:350-354.
DOI
ScienceOn
|
| 67 |
Jia Y, Li ZY, Zhang HG, Li HB, Liu Y, Li XH. Panax notoginseng saponins decrease cholesterol ester via upregulating ATP-binding cassette transporter A1 in foam cells. J Ethnopharmacol 2010;132:297-302.
DOI
ScienceOn
|
| 68 |
Kwak YS, Kyung JS, Kim JS, Cho JY, Rhee MH. Anti-hyperlipidemic effects of red ginseng acidic polysaccharide from Korean red ginseng. Biol Pharm Bull 2010;33:468-472.
DOI
ScienceOn
|
| 69 |
Liu Y, Zhang HG, Jia Y, Li XH. Panax notoginseng saponins attenuate atherogenesis accelerated by zymosan in rabbits. Biol Pharm Bull 2010;33:1324-1330.
DOI
ScienceOn
|
| 70 |
Xia W, Sun C, Zhao Y, Wu L. Hypolipidemic and antioxidant activities of sanchi (radix notoginseng) in rats fed with a high fat diet. Phytomedicine 2011;18:516-520.
DOI
ScienceOn
|
| 71 |
Lee JG, Lee YY, Kim SY, Pyo JS, Yun-Choi HS, Park JH. Platelet antiaggregating activity of ginsenosides isolated from processed ginseng. Pharmazie 2009;64:602-604.
|
| 72 |
Li J, Xie ZZ, Tang YB, Zhou JG, Guan YY. Ginsenoside-Rd, a purifi ed component from Panax notoginseng saponins, prevents atherosclerosis in apoE knockout mice. Eur J Pharmacol 2011;652:104-110.
DOI
ScienceOn
|
| 73 |
Bolli R. Superoxide dismutase 10 years later: a drug in search of a use. J Am Coll Cardiol 1991;18:231-233.
DOI
|
| 74 |
Gross GJ, Farber NE, Hardman HF, Warltier DC. Beneficial actions of superoxide dismutase and catalase in stunned myocardium of dogs. Am J Physiol 1986;250(3 Pt 2):H372- H377.
|
| 75 |
Lee JG, Lee YY, Wu B, Kim SY, Lee YJ, Yun-Choi HS, Park JH. Inhibitory activity of ginsenosides isolated from processed ginseng on platelet aggregation. Pharmazie 2010;65:520-522.
|
| 76 |
Lee YH, Lee BK, Choi YJ, Yoon IK, Chang BC, Gwak HS. Interaction between warfarin and Korean red ginseng in patients with cardiac valve replacement. Int J Cardiol 2010;145:275-276.
DOI
ScienceOn
|
| 77 |
Yi XQ, Li T, Wang JR, Wong VK, Luo P, Wong IY, Jiang ZH, Liu L, Zhou H. Total ginsenosides increase coronary perfusion fl ow in isolated rat hearts through activation of PI3K/Akt-eNOS signaling. Phytomedicine 2010;17:1006-1015.
DOI
ScienceOn
|
| 78 |
Ahn CM, Hong SJ, Choi SC, Park JH, Kim JS, Lim DS. Red ginseng extract improves coronary fl ow reserve and increases absolute numbers of various circulating angiogenic cells in patients with first ST-segment elevation acute myocardial infarction. Phytother Res 2011;25:239-249.
|
| 79 |
Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002;287:356-359.
DOI
ScienceOn
|
| 80 |
Lehmann JM, Kliewer SA, Moore LB, Smith-Oliver TA, Oliver BB, Su JL, Sundseth SS, Winegar DA, Blanchard DE, Spencer TA et al. Activation of the nuclear receptor LXR by oxysterols defi nes a new hormone response pathway. J Biol Chem 1997;272:3137-3140.
DOI
ScienceOn
|
| 81 |
Karu N, Reifen R, Kerem Z. Weight gain reduction in mice fed Panax ginseng saponin, a pancreatic lipase inhibitor. J Agric Food Chem 2007;55:2824-2828.
DOI
ScienceOn
|
| 82 |
Trinh HT, Han SJ, Kim SW, Lee YC, Kim DH. Bifidus fermentation increases hypolipidemic and hypoglycemic effects of red ginseng. J Microbiol Biotechnol 2007;17:1127-1133.
|
| 83 |
Rhee MY, Kim YS, Bae JH, Nah DY, Kim YK, Lee MM, Kim HY. Effect of Korean red ginseng on arterial stiffness in subjects with hypertension. J Altern Complement Med 2011;17:45-49.
DOI
ScienceOn
|
| 84 |
Tamura Y. Effects of Korean red ginseng on eicosanoid biosynthesis in platelets and vascular smooth muscle cells. Proceedings of the 6th Internationa1 Ginseng Symposium; 1993 Sep 6-9; Seoul, Korea. Daejeon: Korea Ginseng & Tobacco Research Institute, 1993.
|
| 85 |
Harima S, Matsuda H, Kubo M. Study of various rhubarbs regarding the cathartic effect and endotoxin-induced disseminated intravascular coagulation. Biol Pharm Bull 1994;17:1522-1525.
DOI
ScienceOn
|
| 86 |
Jin YR, Yu JY, Lee JJ, You SH, Chung JH, Noh JY, Im JH, Han XH, Kim TJ, Shin KS et al. Antithrombotic and antiplatelet activities of Korean red ginseng extract. Basic Clin Pharmacol Toxicol 2007;100:170-175.
DOI
ScienceOn
|
| 87 |
Lee WM, Kim SD, Park MH, Cho JY, Park HJ, Seo GS, Rhee MH. Inhibitory mechanisms of dihydroginsenoside Rg3 in platelet aggregation: critical roles of ERK2 and cAMP. J Pharm Pharmacol 2008;60:1531-1536.
DOI
ScienceOn
|
| 88 |
Li GX, Liu ZQ. The protective effects of ginsenosides on human erythrocytes against hemin-induced hemolysis. Food Chem Toxicol 2008;46:886-892.
DOI
ScienceOn
|
| 89 |
Yang JY, Sun K, Wang CS, Guo J, Xue X, Liu YY, Zheng J, Fan JY, Liao FL, Han JY. Improving effect of posttreatment with Panax notoginseng saponins on lipopolysaccharide- induced microcirculatory disturbance in rat mesentery. Clin Hemorheol Microcirc 2008;40:119-131.
|
| 90 |
Wang J, Huang ZG, Cao H, Wang YT, Hui P, Hoo C, Li SP. Screening of anti-platelet aggregation agents from Panax notoginseng using human platelet extraction and HPLC-DAD-ESI-MS/MS. J Sep Sci 2008;31:1173-1180.
DOI
ScienceOn
|
| 91 |
Lau AJ, Toh DF, Chua TK, Pang YK, Woo SO, Koh HL. Antiplatelet and anticoagulant effects of Panax notoginseng: comparison of raw and steamed Panax notoginseng with Panax ginseng and Panax quinquefolium. J Ethnopharmacol 2009;125:380-386.
DOI
ScienceOn
|
| 92 |
Xu Z, Lan T, Wu W, Wu Y. The effects of ginsenoside on endothelial damage and ghrelin expression induced by hyperhomocysteine. J Vasc Surg 2011;53:156-164.
DOI
ScienceOn
|
| 93 |
Furchgott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J 1989;3:2007-2018.
|
| 94 |
Ignarro LJ. Biological actions and properties of endothelium- derived nitric oxide formed and released from artery and vein. Circ Res 1989;65:1-21.
DOI
ScienceOn
|
| 95 |
Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-142.
|
| 96 |
Leung KW, Cheng YK, Mak NK, Chan KK, Fan TP, Wong RN. Signaling pathway of ginsenoside-Rg1 leading to nitric oxide production in endothelial cells. FEBS Lett 2006;580:3211-3216.
DOI
ScienceOn
|
| 97 |
Kang YJ, Sohn JT, Chang KC. Relaxation of canine corporal smooth muscle relaxation by ginsenoside saponin Rg3 is independent from eNOS activation. Life Sci 2005;77:74-84.
DOI
ScienceOn
|
| 98 |
Wang T, Yu XF, Qu SC, Xu HL, Sui DY. Ginsenoside  inhibits angiotensin II-induced vascular smooth muscle cells proliferation. Basic Clin Pharmacol Toxicol 2010;107:685-689.
DOI
ScienceOn
|
| 99 |
Jovanovski E, Jenkins A, Dias AG, Peeva V, Sievenpiper J, Arnason JT, Rahelic D, Josse RG, Vuksan V. Effects of Korean red ginseng (Panax ginseng C.A. Mayer) and its isolated ginsenosides and polysaccharides on arterial stiffness in healthy individuals. Am J Hypertens 2010;23:469-472.
DOI
|
| 100 |
Lee JY, Lim KM, Kim SY, Bae ON, Noh JY, Chung SM, Kim K, Shin YS, Lee MY, Chung JH. Vascular smooth muscle dysfunction and remodeling induced by ginsenoside , a bioactive component of ginseng. Toxicol Sci 2010;117:505-514.
DOI
ScienceOn
|
| 101 |
Wu L, Zhang W, Tang YH, Li H, Chen BY, Zhang GM, Deng CQ. Effect of total saponins of "Panax notoginseng root" on aortic intimal hyperplasia and the expressions of cell cycle protein and extracellular matrix in rats. Phytomedicine 2010;17:233-240.
DOI
ScienceOn
|
| 102 |
Lei Y, Gao Q, Chen KJ. Effects of extracts from Panax notoginseng and Panax ginseng fruit on vascular endothelial cell proliferation and migration in vitro. Chin J Integr Med 2008;14:37-41.
DOI
ScienceOn
|
| 103 |
Lin KM, Hsu CH, Rajasekaran S. Angiogenic evaluation of ginsenoside Rg1 from Panax ginseng in fluorescent transgenic mice. Vascul Pharmacol 2008;49:37-43.
DOI
ScienceOn
|
| 104 |
Chan LS, Yue PY, Mak NK, Wong RN. Role of microRNA- 214 in ginsenoside-Rg1-induced angiogenesis. Eur J Pharm Sci 2009;38:370-377.
DOI
ScienceOn
|
| 105 |
Hong SJ, Wan JB, Zhang Y, Hu G, Lin HC, Seto SW, Kwan YW, Lin ZX, Wang YT, Lee SM. Angiogenic effect of saponin extract from Panax notoginseng on HUVECs in vitro and zebrafi sh in vivo. Phytother Res 2009;23:677-686.
DOI
ScienceOn
|
| 106 |
Cheung LW, Leung KW, Wong CK, Wong RN, Wong AS. Ginsenoside- induces angiogenesis via non-genomic crosstalk of glucocorticoid receptor and fi broblast growth factor receptor-1. Cardiovasc Res 2011;89:419-425.
DOI
|
| 107 |
Wan JB, Lee SM, Wang JD, Wang N, He CW, Wang YT, Kang JX. Panax notoginseng reduces atherosclerotic lesions in ApoE-deficient mice and inhibits TNF-alphainduced endothelial adhesion molecule expression and monocyte adhesion. J Agric Food Chem 2009;57:6692- 6697.
DOI
ScienceOn
|
| 108 |
Hien TT, Kim ND, Pokharel YR, Oh SJ, Lee MY, Kang KW. Ginsenoside increases nitric oxide production via increases in phosphorylation and expression of endothelial nitric oxide synthase: essential roles of estrogen receptor-dependent PI3-kinase and AMP-activated protein kinase. Toxicol Appl Pharmacol 2010;246:171-183.
DOI
ScienceOn
|
| 109 |
Jeong A, Lee HJ, Jeong SJ, Lee HJ, Lee EO, Bae H, Kim SH. Compound K inhibits basic fi broblast growth factorinduced angiogenesis via regulation of p38 mitogen activated protein kinase and AKT in human umbilical vein endothelial cells. Biol Pharm Bull 2010;33:945-950.
DOI
ScienceOn
|
| 110 |
He W, Wu WK, Wu YL, Yang XH, Lin QX, Yu WH. Ginsenoside- mediates microenvironment-dependent endothelial differentiation of human mesenchymal stem cells in vitro. J Asian Nat Prod Res 2011;13:1-11.
DOI
ScienceOn
|
| 111 |
Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, Browner D. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992;326:381-386.
DOI
ScienceOn
|
| 112 |
Schouten O, Poldermans D. Cardiac risk in non-cardiac surgery. Br J Surg 2007;94:1185-1186.
DOI
ScienceOn
|
| 113 |
He F, Guo R, Wu SL, Sun M, Li M. Protective effects of ginsenoside on human umbilical vein endothelial cells in vitro. J Cardiovasc Pharmacol 2007;50:314-320.
DOI
ScienceOn
|
| 114 |
Leung KW, Leung FP, Huang Y, Mak NK, Wong RN. Non-genomic effects of ginsenoside-Re in endothelial cells via glucocorticoid receptor. FEBS Lett 2007;581: 2423-2428.
DOI
ScienceOn
|
| 115 |
Kim YM, Namkoong S, Yun YG, Hong HD, Lee YC, Ha KS, Lee H, Kwon HJ, Kwon YG, Kim YM. Water extract of Korean red ginseng stimulates angiogenesis by activating the PI3K/Akt-dependent ERK1/2 and eNOS pathways in human umbilical vein endothelial cells. Biol Pharm Bull 2007;30:1674-1679.
DOI
ScienceOn
|
| 116 |
Leung KW, Yung KK, Mak NK, Yue PY, Luo HB, Cheng YK, Fan TP, Yeung HW, Ng TB, Wong RN. Angiomodulatory and neurological effects of ginsenosides. Curr Med Chem 2007;14:1371-1380.
DOI
ScienceOn
|
| 117 |
Nakaya Y, Mawatari K, Takahashi A, Harada N, Hata A, Yasui S. The phytoestrogen ginsensoside Re activates potassium channels of vascular smooth muscle cells through PI3K/Akt and nitric oxide pathways. J Med Invest 2007;54:381-384.
DOI
ScienceOn
|
| 118 |
Papapetropoulos A. A ginseng-derived oestrogen receptor beta (ERbeta) agonist, Rb1 ginsenoside, attenuates capillary morphogenesis. Br J Pharmacol 2007;152:172-174.
DOI
ScienceOn
|
| 119 |
Yu J, Eto M, Akishita M, Kaneko A, Ouchi Y, Okabe T. Signaling pathway of nitric oxide production induced by ginsenoside in human aortic endothelial cells: a possible involvement of androgen receptor. Biochem Biophys Res Commun 2007;353:764-769.
DOI
ScienceOn
|
| 120 |
Yu LC, Chen SC, Chang WC, Huang YC, Lin KM, Lai PH, Sung HW. Stability of angiogenic agents, ginsenoside and Re, isolated from Panax ginseng: in vitro and in vivo studies. Int J Pharm 2007;328:168-176.
DOI
ScienceOn
|
| 121 |
Yook T, Yu J, Lee H, Song B, Kim L, Roh J, Shin J, Lim S. Comparing the effects of distilled rehmannia glutinosa, wild ginseng and astragali radix pharmacopuncture with heart rate variability (HRV): a randomized, sham-controlled and double-blind clinical trial. J Acupunct Meridian Stud 2009;2:239-247.
DOI
ScienceOn
|
| 122 |
Bodiga S, Wang W, Oudit GY. Use of ginseng to reduce post-myocardial adverse myocardial remodeling: applying scientific principles to the use of herbal therapies. J Mol Med (Berl) 2011;89:317-320.
DOI
ScienceOn
|
| 123 |
Zhu D, Wu L, Li CR, Wang XW, Ma YJ, Zhong ZY, Zhao HB, Cui J, Xun SF, Huang XL et al. Ginsenoside protects rat cardiomyocyte from hypoxia/reoxygenation oxidative injury via antioxidant and intracellular calcium homeostasis. J Cell Biochem 2009;108:117-124.
DOI
ScienceOn
|
| 124 |
Kim TH, Lee SM. The effects of ginseng total saponin, panaxadiol and panaxatriol on ischemia/reperfusion injury in isolated rat heart. Food Chem Toxicol 2010;48:1516-1520.
DOI
ScienceOn
|
| 125 |
Wu Y, Xia ZY, Dou J, Zhang L, Xu JJ, Zhao B, Lei S, Liu HM. Protective effect of ginsenoside against myocardial ischemia/reperfusion injury in streptozotocin-induced diabetic rats. Mol Biol Rep 2011;38:4327-4335.
DOI
ScienceOn
|
| 126 |
Guo J, Gan XT, Haist JV, Rajapurohitam V, Zeidan A, Faruq NS, Karmazyn M. Ginseng inhibits cardiomyocyte hypertrophy and heart failure via NHE-1 inhibition and attenuation of calcineurin activation. Circ Heart Fail 2011;4:79-88.
DOI
ScienceOn
|
| 127 |
Tsutsumi YM, Tsutsumi R, Mawatari K, Nakaya Y, Kinoshita M, Tanaka K, Oshita S. Compound K, a metabolite of ginsenosides, induces cardiac protection mediated nitric oxide via Akt/PI3K pathway. Life Sci 2011;88:725-729.
DOI
ScienceOn
|
| 128 |
Zhou H, Hou SZ, Luo P, Zeng B, Wang JR, Wong YF, Jiang ZH, Liu L. Ginseng protects rodent hearts from acute myocardial ischemia-reperfusion injury through GR/ER-activated RISK pathway in an endothelial NOSdependent mechanism. J Ethnopharmacol 2011;135:287-298.
DOI
ScienceOn
|
webmaster
